Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)

被引：0

作者：

Roeth, A. ^{[1
]}

Barcellini, W. ^{[2
]}

Sa, D. S. ^{[3
]}

Miyakawa, Y. ^{[4
]}

Broome, C. M. ^{[5
]}

Michel, M. ^{[6
]}

Kuter, D. J. ^{[7
]}

Jilma, B. ^{[8
]}

Tvedt, Anderson T. H. ^{[9
]}

Lin, S. ^{[10
]}

Jiang, X. ^{[10
]}

Reuter, C. ^{[10
]}

Hobbs, W. ^{[10
]}

Berentsen, S. ^{[11
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, West German Canc Ctr, Essen, Germany

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England

[4] Saitama Med Univ Hosp, Ctr Thrombosis & Hemostasis, Saitama, Japan

[5] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA

[6] UPEC, Henri Mondor Univ Hosp, AP HP, Creteil, France

[7] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA

[8] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[9] Haukeland Hosp, Sect Hematol, Dept Med, Bergen, Norway

[10] Sanofi, Waltham, MA USA

[11] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

237

引用

页码：177 / 177

页数：1

共 50 条

[21] Inflammation and Fatigue in Patients with Cold Agglutinin Disease (CAD): Analysis from the Phase 3 Cardinal Study
Weitz, Ilene C.
Ueda, Yasutaka
Shafer, Frank
Su, Jun
Foster, Meredith
Storek, Michael
Patel, Parija
[J]. BLOOD, 2020, 136
[22] Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Roeth, Alexander
Barcellini, Wilma
Tvedt, Tor Henrik Anderson
Miyakawa, Yoshitaka
Kuter, David J.
Su, Jun
Jiang, Xiaoyu
Hobbs, William
Arias, Jaime Morales
Shafer, Frank
Weitz, Ilene C.
[J]. ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2169 - 2177
[23] Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Alexander Röth
Wilma Barcellini
Tor Henrik Anderson Tvedt
Yoshitaka Miyakawa
David J. Kuter
Jun Su
Xiaoyu Jiang
William Hobbs
Jaime Morales Arias
Frank Shafer
Ilene C. Weitz
[J]. Annals of Hematology, 2022, 101 : 2169 - 2177
[24] Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)
Roeth, Alexander
Bommer, Martin
Huettmann, Andreas
Herich-Terhuerne, Doerte
Kuklik, Nils
Veronika, Lenz
Schrezenmeier, Hubert
Duehrsen, Ulrich
[J]. BLOOD, 2015, 126 (23)
[25] Concomitant Use of Sutimlimab and COVID-19 Vaccines in Patients with Cold Agglutinin Disease from the Phase 3 Cardinal and Cadenza Studies
Fattizzo, Bruno
Roeth, Alexander
Broome, Catherine M.
Khan, Umer
Shafer, Frank
Cordoba, Matias
Barcellini, Wilma
[J]. BLOOD, 2022, 140 : 2839 - 2841
[26] Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)
Jilma, Bernd
Gilbert, James C.
Panicker, Sandip
Parry, Graham C.
Fillitz, Michael
Thomas, Schenk
Sillaber, Christian
Bartko, Johann
Jaeger, Ulrich
[J]. BLOOD, 2016, 128 (22)
[27] Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Jaeger, Ulrich
D'Sa, Shirley
Schoergenhofer, Christian
Bartko, Johann
Derhaschnig, Ulla
Sillaber, Christian
Jilma-Stohlawetz, Petra
Fillitz, Michael
Schenk, Thomas
Patou, Gary
Panicker, Sandip
Parry, Graham C.
Gilbert, James C.
Jilma, Bernd
[J]. BLOOD, 2019, 133 (09) : 893 - 901
[28] Sutimlimab in patients with cold agglutinin disease results of the randomized placebo-controlled phase 3 CADENZA trial
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-ichi
Vos, Josephine M., I
Storek, Michael
Wong, Nancy
Patel, Parija
Jiang, Xiaoyu
Vagge, Deepthi S.
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
[J]. BLOOD, 2022, 140 (09) : 980 - 991
[29] Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study (vol 101, pg 2169, 2022)
Roeth, Alexander
Barcellini, Wilma
Tvedt, Tor Henrik Anderson
Miyakawa, Yoshitaka
Kuter, David J.
Su, Jun
Jiang, Xiaoyu
Hobbs, William
Morales, Jaime
Shafer, Frank
Weitz, Ilene C.
[J]. ANNALS OF HEMATOLOGY, 2024, 103 (5) : 1803 - 1803
[30] Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery
Tvedt, Tor Henrik A.
Steien, Egil
Ovrebo, Bente
Haaverstad, Rune
Hobbs, William
Wardecki, Marek
Tjonnfjord, Geir Erland
Berentsen, Sigbjorn Andreas
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (02) : E51 - E54

← 1 2 3 4 5 →